We remain committed to bringing an ophthalmic bevacizumab to market in the United States and providing retina patients suffering from wet AMD with a much needed treatment option that has the potential ...

EST Outlook Therapeutics (OTLK) files to sell 7.07M shares of common stock for holdersDiscover the Best Stocks and Maximize Your ...

Outlook Therapeutics has re-submitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

Fintel reports that on February 28, 2025, JP Morgan downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from ...

Fintel reports that on February 27, 2025, HC Wainwright & Co. downgraded their outlook for LAVA Therapeutics N.V.

There is huge unmet need for new rare disease therapies, where patients have few or no available options. According to the ...

Molecular Partners will also host a conference call on March 7 on its full-year 2024 financial report. The Annual Report is due to be published March 6. Molecular Partners CEO Patrick Amstutz and CMO ...

The "Macroeconomic Outlook Report: Ireland" country profile has been added to ResearchAndMarkets.com's offering. Dublin, the capital of Ireland, contributed the most to GDP, at 51.6% in 2024, and ...

The "AGCO Corporation - 2025 Strategy Playbook: Strategy Focus, Key Strategies & Plans, SWOT, Trends & Growth Opportunities, Market Outlook" company profile has been added to ResearchAndMarkets.com's ...

The USDA’s Chief Economist was one of the featured speakers during the opening ceremonies of USDA’s Ag Outlook Forum Thursday ...